GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide, and GLP-1 dual/triple receptor agonists, such as Tirzepatide, have shown significant efficacy in treating type 2 diabetes and obesity
However, after responding, the provider closed the chat, so I couldnt ask follow-up questions
Phosphono analogues of glutathione as new inhibitors of glutathione S-transferases [PMID: 8997900] Laboratory literature summary: Phosphono analogues of glutathione as new inhibitors of glutathione S-transferases
If a widely used metabolic drug class is now associated with better long-term survival and lower recurrence in selected breast cancer populations, that naturally raises questions about whether these agents could eventually become part of supportive or even adjunct oncologic care
Oral and intravenous glutathione supplements are available